Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines
Maurizio Sessa, Kristian Kragholm, Anders Hviid, Morten Andersen
Abstract
Our results do support that, when compared to hormonal contraceptive use, the mRNA vaccines do not show disproportional reporting of thromboembolic events in younger women.
Topics & Concepts
MedicineAdverse Event Reporting SystemVaccinationOdds ratioCoronavirus disease 2019 (COVID-19)Adverse effectPediatricsPandemicInternal medicineVirologyDiseaseInfectious disease (medical specialty)Heparin-Induced Thrombocytopenia and ThrombosisBlood Coagulation and Thrombosis MechanismsVenous Thromboembolism Diagnosis and Management